Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.20.4
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Net revenue:      
Total revenues $ 50,118 $ 318 $ 463
Operating expenses:      
Research and development 50,327 52,866 41,382
General and administrative 95,983 22,338 13,694
Amortization of intangible assets 1,289 1,138 1,293
Other expenses (income), net 6,809 14,919 (666)
Total operating expenses 154,408 91,261 55,703
Loss from operations (104,290) (90,943) (55,240)
Interest income 1,516 2,702 2,234
Net loss before income taxes (102,774) (88,241) (53,006)
Income tax benefit (expense) 94 (144) (73)
Net loss and comprehensive loss $ (102,680) $ (88,385) $ (53,079)
Net loss per common share (expressed in $ per share) $ (0.87) $ (0.95) $ (0.63)
Weighted-average common shares outstanding used in computation of basic and diluted loss per share (in dollars per share) 118,473,000 93,024,000 84,782,000
Licensing revenue      
Net revenue:      
Total revenues $ 50,118 $ 318 $ 118
Contract revenue      
Net revenue:      
Total revenues $ 0 $ 0 $ 345